Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
September 5, 2023
CAMP4 Therapeutics to Present at Upcoming Industry and Investor Conferences
Read More
March 21, 2024
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read More
Contact Us
Privacy Policy
Menu
Treatments to help patients reach new heights.
Pause
Main Menu
Top
